Australian Dairy Nutritionals reported a 54% year-on-year revenue fall in the September quarter and held just A$513,000 in cash against a A$619,000 operating cash outflow. The infant formula group is pursuing a A$500,000 placement and a broader capital raise as it waits for China distribution growth and Vietnam sales to rebuild momentum.
- Q1 FY27 revenue fell 54% to A$870,000
- Quarter-end cash declined to A$513,000, equivalent to 0.83 quarters of funding
- Nutritional powders revenue dropped 87% as China orders were delayed and Vietnam sales paused
- A$500,000 Firedragon Capital placement announced after quarter end
- China reached 1,490 active outlets, while Vietnam sales are expected to resume in November
Cash runway falls below one quarter
Australian Dairy Nutritionals Limited (ASX:AHF) ended the September quarter with A$513,000 in cash and no unused finance facilities, leaving it with an estimated 0.83 quarters of funding at the quarter’s operating cash burn. Net cash used in operating activities was A$619,000, while the group’s existing A$1.5 million RELI Capital loan facility was fully drawn.
The funding position arrives alongside a sharp contraction in revenue. Consolidated revenue was A$870,000 in Q1 FY27, down 54% from the prior corresponding quarter and 66% from Q4 FY26. The company said all figures were unaudited.
Nutritional powders retreat as farm revenue improves
The weakness was concentrated in nutritional powders, where revenue fell 87% year on year to A$164,000. Australian Dairy Nutritionals attributed the decline to the timing of distributor orders in China, after Mutree sold through inventory, and a pause in Vietnam sales while product registration was completed.
Farm revenue provided a partial counterweight, rising 22% year on year to A$705,000 and 44% from the previous quarter. The company linked the improvement to more cows milking and favourable seasonal conditions. The contrast leaves the quarter’s growth narrative resting on the farm division while the higher-growth branded nutrition business waits for sales to restart. Earlier in the year, strategic placement funding had supported the group’s expansion plans after nutritional powders revenue surged in FY26.
Capital raising becomes immediate funding test
After quarter end, the board announced a A$500,000 placement with Firedragon Capital and said it remained in discussions with sophisticated and professional investors about a broader capital raising. No completion terms or certainty of success for that wider process were provided in the announcement.
The company said it expects cash flows to increase over the medium term as distribution and sales of its branded infant formula ranges expand. That expectation now has two near-term tests: whether the placement and broader fundraising provide enough liquidity, and whether the sales recovery arrives before cash reserves are exhausted. The group had already secured a fully drawn secured loan earlier in 2026, backed by a 12-month facility carrying a variable interest rate of 9.74% per annum.
China outlet growth and Vietnam restart remain key catalysts
There are operating signs the company hopes can change the equation. Future brand distribution in China reached 1,490 active outlets, with consumer retention reported at 86% in the most recent data. Australian Dairy Nutritionals is targeting 2,000 outlets by the end of FY27, subject to market conditions, with further provincial expansion planned in the December quarter as Mutree implements a revised sales incentive plan.
Vietnam product registration has now been received, and sales are expected to recommence from November 2026. The next quarterly report should therefore show whether the China order cycle normalises and whether Vietnam contributes revenue again, but the immediate financial constraint is less forgiving: without additional funding or a rapid improvement in operating cash flow, the reported cash balance offers limited room for delay.
Bottom Line?
The next funding update may matter as much as the next sales update, with AHF relying on capital raising while China and Vietnam recover.
Questions in the middle?
- Will the A$500,000 Firedragon Capital placement complete, and how much additional capital can the broader raise secure?
- Can China distributor orders and outlet expansion convert reported consumer retention into materially higher quarterly revenue?
- Will Vietnam sales actually resume in November, and what cash contribution will they make before the current runway tightens further?